These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8363375

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis.
    Brook I.
    J Fam Pract; 1994 Feb; 38(2):175-9. PubMed ID: 8308510
    [Abstract] [Full Text] [Related]

  • 4. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis.
    Brook I, Gober AE.
    Arch Otolaryngol Head Neck Surg; 1995 Dec; 121(12):1405-9. PubMed ID: 7488371
    [Abstract] [Full Text] [Related]

  • 5. Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis.
    Brook I.
    Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1501-8. PubMed ID: 17644191
    [Abstract] [Full Text] [Related]

  • 6. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection.
    Brook I.
    Rev Infect Dis; 1984 Oct; 6(5):601-7. PubMed ID: 6390637
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the microbiology of group A and non-group A streptococcal tonsillitis.
    Brook I, Yocum P.
    Ann Otol Rhinol Laryngol; 1988 Oct; 97(3 Pt 1):243-6. PubMed ID: 3132074
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo effects of penicillin and clindamycin on expression of group A beta-hemolytic streptococcal capsule.
    Brook I, Gober AE, Leyva F.
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1565-8. PubMed ID: 7492105
    [Abstract] [Full Text] [Related]

  • 9. Isolation of methicillin resistant Staphylococcus aureus from the surface and core of tonsils in children.
    Brook I, Foote PA.
    Int J Pediatr Otorhinolaryngol; 2006 Dec; 70(12):2099-102. PubMed ID: 16962178
    [Abstract] [Full Text] [Related]

  • 10. Potential mechanisms for failure to eradicate group A streptococci from the pharynx.
    Gerber MA, Tanz RR, Kabat W, Bell GL, Siddiqui Bp, Lerer TJ, Lepow ML, Kaplan EL, Shulman ST.
    Pediatrics; 1999 Oct; 104(4 Pt 1):911-7. PubMed ID: 10506234
    [Abstract] [Full Text] [Related]

  • 11. Recovery of interfering and beta-lactamase-producing bacteria from group A beta-haemolytic streptococci carriers and non-carriers.
    Brook I, Gober AE.
    J Med Microbiol; 2006 Dec; 55(Pt 12):1741-1744. PubMed ID: 17108280
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment Challenges of Group A Beta-hemolytic Streptococcal Pharyngo-Tonsillitis.
    Brook I.
    Int Arch Otorhinolaryngol; 2017 Jul; 21(3):286-296. PubMed ID: 28680500
    [Abstract] [Full Text] [Related]

  • 14. Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis.
    Tanz RR, Shulman ST, Sroka PA, Marubio S, Brook I, Yogev R.
    J Pediatr; 1990 Dec; 117(6):859-63. PubMed ID: 2123240
    [Abstract] [Full Text] [Related]

  • 15. Cefprozil versus penicillin V in treatment of streptococcal tonsillopharyngitis.
    Milatovic D, Adam D, Hamilton H, Materman E.
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1620-3. PubMed ID: 8215273
    [Abstract] [Full Text] [Related]

  • 16. Group A beta-hemolytic streptococcal infections.
    Pichichero ME.
    Pediatr Rev; 1998 Sep; 19(9):291-302. PubMed ID: 9745311
    [Abstract] [Full Text] [Related]

  • 17. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
    McCarty JM.
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):846-50. PubMed ID: 7889958
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
    Cohen R.
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.